India Veterinary Medicine Market Size, Share, Trends and Forecast by Product, Animal Type, Route of Administration, Distribution Channel, and Region, 2026-2034

India Veterinary Medicine Market Summary:

The India veterinary medicine market size was valued at USD 918.47 Million in 2025 and is projected to reach USD 1,580.43 Million by 2034, growing at a compound annual growth rate of 5.38% during 2026-2034.

The India veterinary medicine market is advancing on the back of a vast and the growing livestock population, rising pet humanization trends, and robust government-led animal health programs targeting disease control and food security. Increasing awareness about zoonotic disease risks, expanding veterinary infrastructure, and the adoption of the One Health approach are reinforcing preventive care demand. Continued growth in dairy, poultry, and meat consumption is sustaining livestock healthcare investment, collectively strengthening India veterinary medicine market share.

Key Takeaways and Insights:

• By Product: Drugs dominate the market with a share of 57.1% in 2025, driven by widespread use of therapeutic treatments for infectious diseases, parasitic infections, and metabolic disorders across livestock and companion animals, alongside increasing veterinary consultations and improved availability of pharmaceutical formulations.
   
• By Animal Type: Livestock animals lead the market with a share of 54.7% in 2025, reflecting the large population of cattle, poultry, and small ruminants in India and the growing demand for veterinary medicines to maintain herd health, productivity, and disease management in commercial farming systems.
   
• By Route of Administration: Parenteral represents the largest segment with a market share of 46.2% in 2025, preferred for its rapid therapeutic action, accurate dosage delivery, and effectiveness in treating acute infections and severe health conditions in both livestock and companion animals.
   
• By Distribution Channel: Veterinary hospitals pharmacies dominate the market with a share of 34.8% in 2025, owing to their direct access to veterinarians, reliable prescription-based medicine dispensing, and the growing preference among animal owners for professional treatment and authenticated pharmaceutical products.
   
• By Region: North India leads the market with a share of 30.5% in 2025, supported by a large livestock base, strong dairy and poultry production activities, expanding veterinary healthcare infrastructure, and increasing adoption of animal health products among farmers across the region.
   
• Key Players: The India veterinary medicine market is moderately competitive, featuring a combination of multinational animal health corporations and domestic pharmaceutical companies competing across drugs, vaccines, and medicated feed additives through diverse distribution and innovation strategies. Some of the key players in the market include Ani Healthcare Private Limited, Ashish Life Science Pvt Limited, Century Pharmaceuticals Ltd, GMT Pharma International, Hester Biosciences Limited, Indian Immunologicals Ltd., MarchVET, SSS Pharmachem Pvt. Ltd, Stanex Drugs & Chemicals Pvt. Ltd., Virbac, Zenley Animal Health, Zovix Pharmaceuticals.

To get more information on this market Request Sample

The veterinary medicine market in India is growing due to rising livestock production, increasing awareness about animal health, and stronger policy emphasis on disease prevention and food safety. Livestock farming remains a major income source in rural India, driving demand for vaccines, antibiotics, and nutritional supplements to improve animal productivity and reduce disease-related losses. Government initiatives promoting animal welfare, surveillance of zoonotic diseases, and improvements in veterinary infrastructure are also strengthening the adoption of veterinary medicines across dairy, poultry, and livestock sectors. The growing attention to the One Health approach is further encouraging integration between animal health management and public health systems. In 2025, the President of India highlighted this priority during the Indian Veterinary Research Institute convocation in Bareilly, emphasizing the importance of veterinary science in controlling zoonotic diseases and improving animal welfare while promoting the use of technologies, such as artificial intelligence (AI), genome editing, and data analytics to advance veterinary medicine and livestock care in India.

India Veterinary Medicine Market Trends:

Expansion of Affordable Veterinary Medicine Distribution Networks

The establishment of dedicated veterinary medicine distribution centers is improving access to affordable animal healthcare products for livestock farmers across India. Many rural farmers face difficulties obtaining quality veterinary medicines due to limited availability and high treatment costs. Government-supported distribution networks aim to bridge this gap by supplying generic medicines at subsidized prices through local cooperatives and community-level organizations. These initiatives strengthen livestock health management while supporting rural employment and cooperative participation in animal healthcare delivery. In 2026, the Andhra Pradesh government announced plans to establish 150 Pashu Aushadha Vikraya Kendras that will supply quality generic veterinary medicines at subsidized prices for livestock farmers. The centers will be managed by village-level sheep rearing cooperatives with priority for women, helping reduce treatment costs and strengthening the livestock sector in rural regions.

Strengthening National Disease Prevention Programs

Government-led disease prevention programs are playing an important role in bolstering the veterinary medicine market growth in India. Large-scale national schemes are focusing on vaccination campaigns, disease surveillance systems, and improvements in veterinary healthcare infrastructure to control major livestock diseases. These initiatives help protect animal health, reduce economic losses for farmers, and ensure stable livestock productivity. By promoting preventive treatment and strengthening veterinary service delivery, such programs increase the demand for vaccines, therapeutics, and animal healthcare products across the country. In 2025, the Union Cabinet approved the revision of the Livestock Health and Disease Control Programme to enhance disease management through vaccination drives, mobile veterinary units, and surveillance systems, while introducing the Pashu Aushadhi component to expand access to affordable generic veterinary medicines.

Advanced Vaccine Development

The introduction of advanced veterinary vaccines is strengthening disease control in the poultry sector and supporting the growth for veterinary biologics. Poultry farming is one of the fastest growing livestock segments in India, and disease outbreaks can significantly affect productivity and farm profitability. As a result, poultry producers increasingly rely on modern vaccines designed to provide early and long-lasting immunity against highly infectious diseases. Innovative vaccine technologies are improving protection levels, enabling more efficient flock health management and reducing mortality rates in commercial poultry operations. In 2024, Boehringer Ingelheim launched a next-generation vaccine for Marek’s disease in India that can be administered through in-ovo vaccination or to one-day-old chicks, helping protect poultry against virulent virus strains and improving flock productivity.

Market Outlook 2026-2034:

The India veterinary medicine market is positioned for consistent revenue growth throughout forecast period, supported by structural demand from the livestock sector, accelerating companion animal healthcare spending, and sustained government investment in animal disease control. The market generated a revenue of USD 918.47 Million in 2025 and is projected to reach a revenue of USD 1,580.43 Million by 2034, growing at a compound annual growth rate of 5.38% from 2026-2034. Expanding veterinary infrastructure, increasing parenteral drug adoption, and the emergence of online pharmacy channels are expected to diversify distribution, while progressive regulatory modernization will support product innovation and quality upgrading across the market's growth trajectory.

India Veterinary Medicine Market Report Segmentation: 

Product Insights:

• Drugs
  • Anti-infective
  • Anti-inflammatory
  • Parasiticide
• Vaccines
  • Inactivated Vaccines
  • Attenuated Vaccines
  • Recombinant Vaccines
• Medicated Feed Additives
  • Amino Acids
  • Antibiotics

Drugs dominate with a market share of 57.1% of the total India veterinary medicine market in ‎‎2025.‎

Drugs lead the market due to the widespread need for therapeutic treatments to manage infections, parasites, and other health conditions in animals. Veterinarians frequently prescribe antibiotics, anti-parasitic medicines, anti-inflammatory drugs, and hormonal treatments to maintain the health of livestock and companion animals. Livestock owners rely on these medications to prevent productivity losses caused by disease outbreaks that can affect milk, meat, and egg production. The routine use of veterinary drugs also supports faster recovery and disease control in commercial farming operations. Strong demand for curative and preventive treatments across dairy farms, poultry operations, and pet healthcare continues to drive the consumption of veterinary drugs throughout India.

The growing livestock farming and expanding pet adoption also contribute to the high demand for veterinary drugs in the country. Farmers regularly administer medicines to maintain herd health, improve growth rates, and protect animals from common bacterial and parasitic infections. In addition, veterinary clinics and hospitals prescribe various drugs for treating illnesses in companion animals, such as dogs and cats. Continuous disease monitoring, vaccination follow-ups, and treatment protocols often involve the use of therapeutic drugs as part of routine veterinary care. The consistent requirement for effective medical treatments across both livestock and pet healthcare segments helps maintain the leading share of drugs in the market.

Animal Type Insights:

• Companion Animals
• Livestock Animals

Livestock animals lead with a market share of 54.7% of the total India veterinary medicine market in ‎‎2025.‎

Livestock animals dominate the market owing to the country’s large population of cattle, poultry, sheep, and goats that require continuous healthcare management. Livestock farming plays an important role in supporting rural incomes and food production, particularly in dairy and poultry industries. Farmers regularly use veterinary medicines, including vaccines, antibiotics, anti-parasitic drugs, and nutritional supplements, to maintain animal health and productivity. Preventing disease outbreaks is essential for protecting milk, meat, and egg production, which encourages consistent veterinary treatment and vaccination practices. The scale of livestock farming across India creates strong and sustained demand for veterinary pharmaceuticals and healthcare products.

Rising demand for dairy products, poultry meat, and eggs is increasing the need for veterinary medicines to maintain livestock health and productivity in India. Commercial dairy farms and poultry producers rely on routine vaccination, disease prevention, and nutritional treatments to sustain output and reduce mortality risks. Reflecting this focus on livestock healthcare access, in 2025, the Government of India announced plans to launch Pashu Aushadhi Kendras nationwide under the revised Livestock Health and Disease Control Programme to provide affordable generic veterinary medicines through cooperative societies and PM-Kisan Samriddhi Kendras. Such initiatives support wider medicine distribution and strengthen preventive healthcare practices across livestock farming systems.

Route of Administration Insights:

• Oral
• Parenteral
• Topical

Parenteral exhibits a clear dominance with a 46.2% share of the total India veterinary medicine market in ‎‎2025.‎

Parenteral holds the biggest market share driven by its effectiveness in delivering rapid therapeutic results for livestock and companion animals. Injectable medicines allow veterinarians to administer accurate dosages directly into the bloodstream or muscle, ensuring faster absorption compared to oral treatments. This method is widely used for antibiotics, vaccines, hormones, and anti-parasitic drugs required to treat infections and prevent disease outbreaks in animals. Livestock farmers often prefer injectable medications because they provide immediate action during critical health conditions. The reliability of parenteral administration in managing serious diseases and improving treatment outcomes contributes to its strong demand within veterinary healthcare practices across India.

Widespread vaccination programs and disease prevention initiatives also support the dominance of parenteral administration in the market. Government and private veterinary services regularly conduct immunization campaigns for cattle, poultry, and other livestock to control infectious diseases, such as foot-and-mouth disease and brucellosis. Most vaccines used in these programs are administered through injections, increasing the demand for parenteral formulations. In addition, veterinarians rely on injectable treatments when animals are unable to consume oral medicines due to illness or stress. The need for precise dosing, rapid response, and reliable disease control continues to strengthen the use of parenteral routes in veterinary treatment practices throughout India.

Distribution Channel Insights:

Access the comprehensive market breakdown Request Sample

• Veterinary Hospitals Pharmacies
• Retail Veterinary Pharmacies
• Online Pharmacies

Veterinary hospitals pharmacies dominate with a market share of 34.8% of the total India veterinary medicine market in ‎‎2025.‎

Veterinary hospitals pharmacies represent the largest segment because of their direct role in diagnosing animal health conditions and prescribing appropriate treatments. Livestock owners and pet parents commonly purchase medicines from veterinary hospitals after consulting veterinarians who recommend specific drugs, vaccines, or nutritional supplements. This channel ensures that medicines are used correctly according to professional guidance, which is particularly important for treating infections, parasitic diseases, and other health issues in animals. Veterinary hospitals also maintain a reliable supply of commonly used medicines to support ongoing treatment programs. As a result, these facilities remain a primary and trusted source for veterinary medicine distribution across many parts of India.

The expanding network of veterinary hospitals and clinics is strengthening access to animal healthcare and supporting the distribution of veterinary medicines across India. Government veterinary hospitals and private veterinary clinics serve as primary centers for disease diagnosis, vaccination, and treatment for both livestock and companion animals. Reflecting this trend, in 2025, Zigly launched its first pet hospital in Mumbai, expanding its tech-enabled omnichannel pet care network that provided consultations, diagnostics, surgeries, vaccinations, and pharmacy services under one facility. The growing presence of such healthcare facilities improves medicine availability, ensures proper prescription guidance, and supports greater adoption of veterinary treatments among livestock owners and pet caregivers.

Regional Insights:

• North India
• West and Central India
• South India
• East India

North India leads with a market share of 30.5% of the total India veterinary medicine market in ‎‎2025.‎

North India accounts for the biggest market share attributed to the region’s large livestock population and strong agricultural base. States, such as Uttar Pradesh, Punjab, Haryana, and Rajasthan maintain significant cattle, poultry, and dairy farming activities that require consistent veterinary care and disease management. Farmers in these areas regularly use veterinary medicines, including antibiotics, vaccines, anti-parasitic drugs, and nutritional supplements to maintain animal health and productivity. The presence of well-established dairy cooperatives and commercial poultry farms further increases the demand for veterinary treatments. As livestock plays an important role in rural livelihoods and dairy production, veterinary medicine usage remains high across North India.

The growing awareness about animal health management also contributes to strong veterinary ‎medicine sales across the region. Government initiatives supporting livestock development, ‎vaccination drives, and veterinary healthcare services encourage farmers to adopt preventive ‎treatments for livestock diseases. Veterinary hospitals, clinics, and mobile animal healthcare ‎units are widely available in many northern states, improving access to medicines and ‎professional care. For example, in 2026: The Punjab government announced plans to launch ‘Blue Cross’ veterinary medicine stores in six districts to improve access to animal healthcare. The stores will offer discounts of 30% on generic veterinary medicines and 20% on branded medicines to support livestock farmers. The initiative aims to reduce treatment costs and strengthen the rural livestock economy by expanding affordable veterinary medicine availability.

Market Dynamics:

Growth Drivers:

Why is the India Veterinary Medicine Market Growing?

Improving Veterinary Healthcare Infrastructure and Service Availability

The expansion of veterinary healthcare infrastructure is improving access to professional animal health services and supporting the distribution of veterinary medicines across India. Government veterinary hospitals, private clinics, and specialized animal healthcare centers are increasingly being established in both urban and semi-urban areas to meet rising demand for veterinary services. These facilities enable early disease diagnosis, vaccination programs, surgical care, and preventive treatments for both livestock and companion animals. Reflecting this trend, in 2025, DCC Animal Hospital launched its first veterinary hospital in Jaipur, offering preventive care, diagnostics, and surgical services designed according to global and Japanese veterinary standards. Such developments strengthen the veterinary care ecosystem, encourage routine health monitoring, and increase the use of vaccines, pharmaceuticals, and therapeutic treatments across India’s expanding animal healthcare sector.

Digitization of Veterinary Drug Regulatory Processes

The digitization of regulatory approval systems is improving efficiency and transparency in the veterinary pharmaceutical sector in India. Regulatory authorities are adopting online platforms for submitting and reviewing applications related to veterinary drugs, vaccines, and pharmaceutical ingredients. Digital systems reduce paperwork, streamline communication between companies and regulators, and shorten approval timelines for new veterinary products. Faster regulatory processes help pharmaceutical companies bring innovative treatments and vaccines to market more efficiently, strengthening product availability for veterinarians and livestock producers. In 2024, the Central Drugs Standard Control Organization mandated the online submission of applications for veterinary drug approvals through the SUGAM portal, covering new drugs, vaccines, active pharmaceutical ingredients, finished formulations, and field trial permissions.

Advancements in Animal Biotechnology and Regenerative Medicine

Biotechnology research is opening new opportunities for improving animal health and productivity in India’s veterinary sector. Scientific advancements in areas, such as regenerative medicine, disease modeling, and reproductive biotechnology, are enabling researchers to develop new treatment approaches and improve livestock breeding outcomes. These innovations support the development of advanced therapies and improved diagnostic capabilities for managing complex animal health conditions. Dedicated research infrastructure is also helping expand scientific collaboration and accelerate discoveries related to veterinary medicine. In 2025, India inaugurated its first Animal Stem Cell Biobank and Animal Stem Cell Laboratory at the National Institute of Animal Biotechnology in Hyderabad. The facility will support regenerative medicine research and advanced biotechnology applications aimed at improving livestock health and productivity across the country.

Market Restraints:

What Challenges the India Veterinary Medicine Market is Facing?

Inadequate Veterinary Infrastructure in Rural and Remote Areas

Limited veterinary infrastructure across rural and semi-urban regions restricts consistent access to professional animal healthcare services. Many livestock-dense areas lack sufficient veterinary facilities, trained professionals, and reliable medicine distribution networks. Inadequate cold chain capacity and logistical limitations further hinder the effective delivery of vaccines and temperature-sensitive products. These gaps reduce treatment accessibility, delay disease management, and limit the overall reach of veterinary medicines across dispersed agricultural regions.

Prevalence of Counterfeit and Substandard Veterinary Medicines

The presence of counterfeit and substandard veterinary medicines within fragmented distribution networks poses a major challenge for the industry. Inferior products weaken treatment outcomes, undermine confidence among farmers and veterinarians, and create unfair competition for legitimate manufacturers. Weak monitoring across informal supply channels allows low-quality products to circulate in price-sensitive markets, distorting purchasing behavior and constraining revenue growth for compliant pharmaceutical producers.

Low Awareness and Adoption of Preventive Healthcare in Livestock Farming

Preventive healthcare practices remain limited among many livestock farmers, particularly in rural agricultural communities. A large segment of producers continues to rely on reactive treatment approaches rather than regular vaccination, deworming, and nutritional supplementation programs. Limited access to veterinary guidance, insufficient farmer education initiatives, and communication barriers reduce understanding of long-term animal health management. These factors restrict consistent veterinary medicine usage and slow demand expansion across India’s livestock sector.

Competitive Landscape:

The India veterinary medicine market exhibits a moderately competitive structure, supported by the presence of multinational pharmaceutical companies, established domestic manufacturers, and regional animal health product suppliers. Large companies compete through broad product portfolios, strong distribution networks, and ongoing investment in research, manufacturing, and regulatory compliance. Domestic firms play an important role by offering cost-competitive medicines and expanding supply across rural and semi-urban livestock markets. Competition is shaped by product quality, pricing strategies, veterinary outreach programs, and partnerships with distributors, cooperatives, and veterinary service providers. Companies also focus on expanding production capabilities, strengthening supply chains, and improving product availability across livestock and companion animal segments. Continued growth in animal healthcare demand is encouraging manufacturers to widen their presence across diverse regional markets.

Some of the key players in the market include:‎

• Ani Healthcare Private Limited
• Ashish Life Science Pvt Limited
• Century Pharmaceuticals Ltd
• GMT Pharma International
• Hester Biosciences Limited
• Indian Immunologicals Ltd.‎
• MarchVET
• SSS Pharmachem Pvt. Ltd
• Stanex Drugs & Chemicals Pvt. Ltd.‎
• Virbac
• Zenley Animal Health
• Zovix Pharmaceuticals

Recent Developments:

• February 2026: The Government of India announced a coordinated regulatory framework to strengthen oversight of veterinary medicines, vaccines, and biological drugs. The Department of Animal Husbandry and Dairying established the Empowered Committee on Animal Health-Regulatory to provide technical recommendations to CDSCO on veterinary drug approvals. The framework also supports responsible antibiotic use, veterinary treatment guidelines, and disease control programs to improve livestock health and medicine safety.

• January 2026: Boehringer Ingelheim India partnered with Alivira Animal Health Limited to distribute and promote its companion animal medicines portfolio across India. The collaboration aims to expand access to veterinary medicines by leveraging Alivira’s distribution network in both urban and rural markets. The partnership targets the growing pet healthcare segment driven by rising pet ownership and demand for preventive animal care medicines.

India Veterinary Medicine Market Report Coverage: